Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease (original) (raw)
Preservation of acetylcholine muscarinic M2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease* 1
Angel Hernandez
Neuroscience …, 1995
View PDFchevron_right
Preservation of acetylcholine muscarinic M2 receptor G-protein interactions 1995
Abdu Adem
View PDFchevron_right
Acetylcholine Muscarinic M2 Receptor Stimulated [35S]GTPγS Binding Shows Regional Selective Changes in Alzheimer's Disease Postmortem Brain
rivka ravid
Neurodegeneration, 1996
View PDFchevron_right
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease
Christopher P.l.h. Chen
Neurobiology of Aging, 2006
View PDFchevron_right
Coupling of muscarinic receptors to GTP proteins in postmortem human brain — alterations in Alzheimer's disease
Agneta Nordberg
Neuroscience Letters, 1993
View PDFchevron_right
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1–42
Vladimír Doležal
Neuropharmacology, 2013
View PDFchevron_right
The Potential for Muscarinic Receptor Subtype-Specific Pharmacotherapy for Alzheimer's Disease
Joseph T Coyle
Mayo Clinic Proceedings, 1991
View PDFchevron_right
Abnormalities in muscarinic cholinergic receptors and their G-protein coupling systems in the cerebral frontal cortex in Alzheimer's disease
Masato Asanuma
Archives of Gerontology and Geriatrics, 1993
View PDFchevron_right
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease
Christopher P.l.h. Chen
Neurobiology of Aging, 2007
View PDFchevron_right
Inhibitor of antagonist binding to the muscarinic receptor is elevated in Alzheimer's brain
Thomas Ala
Brain Research, 1994
View PDFchevron_right
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients 2003
Abdu Adem
View PDFchevron_right
Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides
David Gurwitz
Proceedings of the National Academy of Sciences, 1984
View PDFchevron_right
Coupling of human brain cerebral cortical α2-adrenoceptors to GTP-binding proteins in Alzheimer's disease
Bengt Winblad
Brain Research, 1991
View PDFchevron_right
Agonist binding to M1 muscarinic receptors is sensitive to guanine nucleotides
nick palermo
European Journal of Pharmacology: Molecular Pharmacology, 1989
View PDFchevron_right
Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide
Frederick Ehlert
Journal of supramolecular structure, 1980
View PDFchevron_right
Loss of Muscarinic M 1 Receptor Exacerbates Alzheimer's Disease–Like Pathology and Cognitive Decline
Frank LaFerla
Asian Journal of Psychiatry, 2011
View PDFchevron_right
Haga, K., Haga, T. & Ichiyama, A. Reconstitution of the muscarinic acetylcholine receptor. Guanine nucleotide-sensitive high affinity binding of agonists to purified muscarinic receptors reconstituted with GTP-binding proteins (Gi and Go). J. Biol. Chem. 261, 10133-10140
T. Haga
Journal of Biological Chemistry
View PDFchevron_right
Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model
Allan Levey
ACS chemical neuroscience, 2017
View PDFchevron_right
Interaction of muscarinic acetylcholine receptors and three kinds of GTP-binding proteins (Gi, Go and Gn) purified from porcine cerebrum and atrium
Gabriel Berstein
Neuroscience Research Supplements, 1988
View PDFchevron_right
Muscarinic acetylcholine receptor-expression in astrocytes in the cortex of young and aged rats
E. Van Der Zee
Glia, 1993
View PDFchevron_right
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Christian Felder
Brain Research, 2002
View PDFchevron_right
Neuroprotective and Antioxidant Role of Oxotremorine-M, a Non-selective Muscarinic Acetylcholine Receptors Agonist, in a Cellular Model of Alzheimer Disease
Giuseppa Mudò
Cellular and Molecular Neurobiology
View PDFchevron_right
Muscarinic receptors and novel strategies for the treatment of age-related brain disorders
William Roeske
Life Sciences, 1994
View PDFchevron_right
Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease
Christian Felder
Journal of chemical neuroanatomy, 2010
View PDFchevron_right
Endogenous Alzheimer's Brain Factor and Oxidized Glutathione Inhibit Antagonist Binding to the Muscarinic Receptor
John Frank
Brain research, 1996
View PDFchevron_right
Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease
Paul Luiten
Brain Research Bulletin, 1991
View PDFchevron_right
cGMP formation and phosphoinositide turnover in rat brain slices are mediated by pharmacologically distinct muscarinic acetylcholine receptors
Thijs de Boer
European Journal of Pharmacology: Molecular Pharmacology, 1991
View PDFchevron_right
Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands
Abraham Fisher
European Journal of Pharmacology: Molecular Pharmacology, 1994
View PDFchevron_right
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer’s disease
Abraham Fisher
Journal of Neurochemistry, 2012
View PDFchevron_right
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis
Daniele Marciano
Journal of Physiology-Paris, 1998
View PDFchevron_right
Functional characterization of muscarinic autoreceptors in rat and human neocortex
Rolf Jackisch
Journal of Neurochemistry, 2009
View PDFchevron_right
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease
Sean Colloby
Journal of Chemical Neuroanatomy, 2003
View PDFchevron_right
Uncoupling of muscarinic cholinergic phosphoinositide signals in senescent cerebral cortical and hippocampal membranes
James Joseph
Neurochemistry International, 1998
View PDFchevron_right